Impact of screening on incidence and mortality of prostate cancer in the United States

Epidemiologic Reviews

Volumn 23, Issue 1, 2001, Pages 181-186

  Potosky, Arnold L ^a   Feuer, Eric J ^a   Levin, David L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER SCREENING; HUMAN; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; UNITED STATES;

EID: 0034810595     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.epirev.a000787     Document Type: Review

References (35)

1. Rapid rise and subsequent decline in prostate cancer incidence rates for New Mexico, 1989-1993
2. The fall in incidence of prostate carcinoma: On the down side of a prostate specific antigen induced peak in incidence - Data from the Utah Cancer Registry
3. Trends in prostate carcinoma incidence in Connecticut (1988-1994) by age and race
4. Trends in the stage specific incidence of prostate carcinoma in the Detroit metropolitan area, 1973-1994
5. The changing epidemiology of prostate cancer in Seattle-Puget Sound region, 1974-1993
6. Increasing incidence of cancer of the prostate: The experience of black and white men in the Detroit metropolitan area
7. The role of increasing detection in the rising incidence of prostate cancer
8. The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States
9. Longitudinal screening for prostate cancer with prostate-specific antigen
10. The American Cancer Society National Prostate Cancer Detection Project: Findings on the detection of early prostate cancer in 2425 men
11. Changes in prostate cancer incidence and treatment in USA
12. Cancer surveillance series: Interpreting trends in prostate cancer - Part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates
13. Trends in poorly differentiated prostate cancer 1973 to 1994: Observations from the Surveillance, Epidemiology and End Results database
14. The results of prostate carcinoma screening in the US as reflected in the Surveillance, Epidemiology, and End Results program
15. The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the US: The American College of Surgeons Commission on Cancer and the American Cancer Society
16. Asymptomatic incidence and duration of prostate cancer
17. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening
18. Characteristics of prostate cancer detected in the American Cancer Society-National Prostate Cancer Detection Project
19. Serum prostate specific antigen as pre-screening test for prostate cancer
20. Prevalence of latent prostate carcinoma in two US populations
21. Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates
22. Prostate cancer screening: What we know and what we need to know
23. Cancer surveillance series: Interpreting trends in prostate cancer - Part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality
24. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
25. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer
26. Estimating unknown transition times using a piecewise nonlinear mixed-effects model in men with prostate cancer
27. Changes in the use of radical prostatectomy for treating prostate cancer in the USA
28. Single-therapy androgen suppression in men with advanced prostate cancer: A systematic review and meta-analysis
29. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer
30. A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995
31. Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort
32. Patient-reported symptoms after primary therapy for early prostate cancer: Results of a prospective cohort study
33. Outcomes of external-beam radiation therapy for prostate cancer: A study of Medicare beneficiaries in three Surveillance, Epidemiology, and End Results areas
34. Health outcomes after prostatectomy or radiotherapy for prostate cancer: Results from the Prostate Cancer Outcomes Study
35. The European Randomized Study of Screening for Prostate Cancer (ERSPC)